Journalartikel

Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists


AutorenlisteGossec, L.; Bijlsma, J. W. J.; Bombardier, C.; Canhao, H.; Devlin, J.; Edwards, C. J.; Hamuryudan, V.; Kvien, T. K.; Leeb, B. F.; Martin-Mola, E. M.; Mielants, H.; Mueller-Ladner, U.; Ostergaard, M.; Pereira, I. A.; Ramos-Remus, C.; Zochling, J.; Dougados, Maxime

Jahr der Veröffentlichung2011

Seiten388-U180

ZeitschriftAnnals of the Rheumatic Diseases

Bandnummer70

Heftnummer2

ISSN0003-4967

DOI Linkhttps://doi.org/10.1136/ard.2010.128652

VerlagElsevier



Zitierstile

Harvard-ZitierstilGossec, L., Bijlsma, J., Bombardier, C., Canhao, H., Devlin, J., Edwards, C., et al. (2011) Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists, Annals of the Rheumatic Diseases, 70(2), pp. 388-U180. https://doi.org/10.1136/ard.2010.128652

APA-ZitierstilGossec, L., Bijlsma, J., Bombardier, C., Canhao, H., Devlin, J., Edwards, C., Hamuryudan, V., Kvien, T., Leeb, B., Martin-Mola, E., Mielants, H., Mueller-Ladner, U., Ostergaard, M., Pereira, I., Ramos-Remus, C., Zochling, J., & Dougados, M. (2011). Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists. Annals of the Rheumatic Diseases. 70(2), 388-U180. https://doi.org/10.1136/ard.2010.128652



Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-02-04 um 02:57